Enhancement of Physical Activity in Elderly Patients With Diastolic Heart Failure by a Motivational Intervention
Ex-DHFadd-on
1 other identifier
interventional
39
0 countries
N/A
Brief Summary
The aim of our pilot study is to evaluate the feasibility, acceptance and efficacy of motivational interviewing (MI) to support elderly patients with heart failure with preserved ejection fraction (HFpEF) in maintaining or starting physical activity (PA).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jun 2013
Typical duration for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 18, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 8, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
December 8, 2015
CompletedFirst Submitted
Initial submission to the registry
December 22, 2017
CompletedFirst Posted
Study publicly available on registry
January 18, 2018
CompletedJanuary 18, 2018
January 1, 2018
2.5 years
December 22, 2017
January 17, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
Adherence to intervention
To evaluate the feasibility of motivational counseling to enhance physical activity patients´ adherence to appointments is assessed as number / percentage of sessions attended
Over 6 month intervention period
Patient acceptance of intervention
To assess how patients evaluate the Intervention, i.e. receiving motivational counseling, they were asked to fill in evaluation sheets
At 6-month assessment
Effectiveness (peak VO2)
Changes in the maximal exercise capacity (peak VO2) during a symptom-limited cardiopulmonary exercise test on a bicycle ergometer.
Change from baseline to 6-month assessment
Effectiveness (6-minute walk distance)
Six-minutes walking distance
Change from baseline to 6-month assessment
Other Outcomes (2)
Motivation
Change from baseline to 6-month assessment.
Physical activity
Change from baseline to 6-month assessment.
Study Arms (2)
Motivational interviewing
EXPERIMENTALOver a time span of 6 months, participants in the intervention group received up to 7 sessions of motivational counseling, lasting 15-30 minutes each, to enhance physical activity.
Usual care
NO INTERVENTIONParticipants who served as controls received usual care.
Interventions
Eligibility Criteria
You may qualify if:
- preserved left ventricular systolic function (left ventricular ejection fraction \>= 50%),
- echocardiographically determined diastolic dysfunction (grade ≥ 1),
- New York Heart association functional classes I, II or III,
- at least one cardiovascular risk-factor (overweight, diabetes, hypertension, smoking or hyperlipidemia)
- participation in Ex-DHF main study
- written informed consent
You may not qualify if:
- Non-cardiac causes for heart failure-like symptoms
- Chronic obstructive pulmonary disease GOLD stages ≥II
- Anaemia (haemoglobin \<11 mg/dL)
- Significant renal dysfunction (eGFR \<30 mL/min/1.73 m\*\*2 indexed to BSA)
- Significant peripheral artery disease (Fontaine ≥IIb)
- Musculoskeletal disease that contributes to reduced exercise performance
- Specific cardiomyopathy (e.g. amyloidosis)
- Haemodynamically significant valvular disorders
- Significant coronary artery disease (current angina pectoris Canadian Cardiovascular Society Class ≥II or positive stress test, myocardial infarction or coronary artery bypass graft within the last 3 months)
- Any inability or contraindication to participate in cardiopulmonary exercise testing or in an exercise programme (e.g. physiological, mental) or to supply essential information (e.g. questionnaire, diary)
- Ineffective control of resting blood pressure (≥140/90 mmHg or ≥160/100 mmHg with ≥3 antihypertensive drugs) or of resting heart rate (≥100 b.p.m.)
- Expected low adherence (e.g. by travel distance to trial site; planned absences longer than 4 weeks during follow-up) or ongoing drug abuse
- Pregnant or nursing women
- Concomitant participation in other interventional clinical trials
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Prof. Dr.
Study Record Dates
First Submitted
December 22, 2017
First Posted
January 18, 2018
Study Start
June 18, 2013
Primary Completion
December 8, 2015
Study Completion
December 8, 2015
Last Updated
January 18, 2018
Record last verified: 2018-01